Inventor
Brian Froehler
Inventor
Belmont, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Hprimary
C07HSugars42%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms25%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
C07DHeterocyclic compounds5%
C40BCombinatorial chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12NMicroorganisms or enzymes4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
A61KPreparations for medical, dental or toiletry purposes2%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations2%
PatentTitleYear
8,653,248'2-aminopyridine and 2-pyridone C-nucleosides'20147,057,027'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20066,962,783'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20056,875,593'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20056,756,496'Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues'20046,495,672'Oligonucleotides including 2-aminopyridine and 2-pyridone C-nucleoside units'20026,447,998'2-Aminopyridine and 2-pyridone C-nucleosides, oligonucleotides comprising, and tests using the same oligonucleotides'20026,380,368'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20026,300,486'Large scale synthesis of oligonucleotides and their associated analogs'20016,235,887'Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines'20015,830,653'Methods of using oligomers containing modified pyrimidines'19985,721,218'Oligonucleotides with inverted polarity'19985,672,697'Nucleoside 5\'-methylene phosphonates'19975,645,985'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'19975,594,121'Enhanced triple-helix and double-helix formation with oligomers containing modified purines'19975,565,555'Nucleoside hydrogen phosphonodithioate diesters and activated phosphonodithioate analogues'19965,548,076'Method of making oligonucleotides, oligonucleoside thiophosphates and oligonucleoside phosphotriesters using H-phosphonate intermediates'19965,527,899'Oligonucleotides with inverted polarity'19965,484,908'Oligonucleotides containing 5-propynyl pyrimidines'19965,399,676'Oligonucleotides with inverted polarity'19955,264,566'Method for in vitro oligonucleotide synthesis using H-phosphonates'19935,256,775'Exonuclease-resistant oligonucleotides'19935,204,455'Monomethoxytrityl protected oligonucleotides bound to a solid support'19935,194,599'Hydrogen phosphonodithioate compositions'19935,164,491'Large scale synthesis of oligonucleotides and their associated analogs'19924,959,463'Intermediates'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1996Patents assigned to GENENTECH INC (3)· patent assignee history
1990–2014Based in Belmont, CA, US· patent location history
1992–1995Patents assigned to GILEAD SCIENCES (2)· patent assignee history
1993–1998Patents assigned to GILEAD SCIENCES INC (10)· patent assignee history
1993–2014Patents assigned to FROEHLER BRIAN C (2)· patent assignee history
2001–2014Patents assigned to ISIS PHARMACEUTICALS INC (10)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 10 | 1993–1998 |
| ISIS PHARMACEUTICALS INC | 10 | 2001–2014 |
| GENENTECH INC | 3 | 1990–1996 |
| FROEHLER BRIAN Cself | 2 | 1993–2014 |
| GILEAD SCIENCES | 2 | 1992–1995 |
Locations
| Location | Patents | Span |
|---|---|---|
| Belmont, California, US | 26 | 1990–2014 |